Epidemiology of amyotrophic lateral sclerosis: a population-based analysis, 2015–2020
Authors:
- 11 July 2025
- journal article
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Vol. 26 (7-8) , 784-793
Abstract
Background: Epidemiological data on amyotrophic lateral sclerosis (ALS) in Spain have primarily been derived from small cohort studies, with limited information on survival and comorbidities. This study presents a 10-year follow-up of a large, well-phenotyped community-dwelling ALS cohort in Catalonia, Spain. Methods: This observational study utilized data from the Information System for the Development of Research in Primary Care (SIDIAP), which includes health records for 6,301,095 individuals from 2015 to 2020. We assessed ALS incidence, prevalence, comorbidities, territorial distribution, mortality, and survival times. Results: From 2015 to 2020, 1173 ALS cases were identified, with a median age at diagnosis of 68 years, and 50.4% of cases were female. Incidence and prevalence were estimated at 2.39 per 100,000 person-years and 7.98 cases per 100,000 persons. Dementia was present in 6.8% of cases before ALS diagnosis, while depression and/or anxiety affected 45.7%. Median survival from diagnosis was 2.19 years. Multivariate analysis identified older age at diagnosis (HR: 1.04, 95% CI: 1.04-1.05, p value < 0.001), alcohol abuse (HR: 1.56, 95% CI: 1.04-2.56, p value = 0.017), history of stroke (HR: 1.47, 95% CI: 1.07-2.04, p = 0.006), and dementia (HR: 1.57, 95% CI: 1.18-2.12, p value = 0.001) as independent predictors of mortality. Conclusions: ALS incidence and prevalence in Catalonia are higher than previously estimated for Spain and align closely with rates observed in other Western countries. Older age at diagnosis, alcohol abuse, stroke history, and dementia were all significantly associated with reduced survival. These findings underscore important risk factors affecting prognosis, offering valuable insights into ALS progression.Keywords
This publication has 43 references indexed in Scilit:
- Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United StatesMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2024
- Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc StudyJournal of Neurology, 2024
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2023
- Incidence of amyotrophic lateral sclerosis in older adultsMuscle & Nerve, 2022
- Cardiovascular comorbidities in amyotrophic lateral sclerosis: A systematic reviewJournal of Clinical Neuroscience, 2022
- Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosisJournal of the Neurological Sciences, 2020
- Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient groupJournal of Neurology, 2020
- Psychiatric disorders prior to amyotrophic lateral sclerosisAnnals of Neurology, 2016
- Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithmJournal of Neurology, 2015
- Cognitive impairment in amyotrophic lateral sclerosisThe Lancet Neurology, 2007